Narsoplimab for severe transplant-associated thrombotic microangiopathy

Narsoplimab for severe transplant-associated thrombotic microangiopathy

Abstract Background Transplantation-associated thrombotic microangiopathy (TA-TMA) is an endothelial injury syndrome linked to the overactivation of complement pathways. It manifests with microangiopathic hemolytic anemia, consumptive thrombocytopenia, and microvascular thrombosis leading to ischemi...

Full description

Bibliographic Details
Main Authors: Ambreen Pandrowala, Parth Ganatra, V. P. Krishnan, Ajay Narayan Sharma, Saroj Chavan, Minnie Bodhanwala, Bharat Agarwal, Prashant Hiwarkar
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Thrombosis Journal
Subjects:
Transplant-associated thrombotic microangiopathy
Narsoplimab
Lectin pathway inhibitor
Online Access:https://doi.org/10.1186/s12959-023-00464-9

Internet

https://doi.org/10.1186/s12959-023-00464-9

Similar Items